Amanda Benjamin

495 total citations
5 papers, 156 citations indexed

About

Amanda Benjamin is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Amanda Benjamin has authored 5 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Cancer Research. Recurrent topics in Amanda Benjamin's work include Biosimilars and Bioanalytical Methods (2 papers), RNA modifications and cancer (1 paper) and Immunotoxicology and immune responses (1 paper). Amanda Benjamin is often cited by papers focused on Biosimilars and Bioanalytical Methods (2 papers), RNA modifications and cancer (1 paper) and Immunotoxicology and immune responses (1 paper). Amanda Benjamin collaborates with scholars based in United Kingdom, United States and Sweden. Amanda Benjamin's co-authors include Paul D. Smith, Lorraine Mooney, Mitchell Revill, Mike Firth, Nicola J. Curtis, Armelle Logié, Filippos Michopoulos, Haihong Zhong, Clare Murray and Kate F. Byth and has published in prestigious journals such as British Journal of Pharmacology, Drug Discovery Today and Oncotarget.

In The Last Decade

Amanda Benjamin

5 papers receiving 154 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amanda Benjamin United Kingdom	4	97	87	31	25	17	5	156
Tyler M. Hudish United States	8	155 1.6×	83 1.0×	79 2.5×	30 1.2×	20 1.2×	8	343
Jiapei Lv China	10	202 2.1×	110 1.3×	40 1.3×	16 0.6×	18 1.1×	16	281
Hermon Kihshen United States	2	183 1.9×	110 1.3×	16 0.5×	12 0.5×	13 0.8×	2	231
Zhaoyue Zheng China	6	104 1.1×	59 0.7×	22 0.7×	22 0.9×	11 0.6×	8	206
Carles Foguet Spain	8	123 1.3×	49 0.6×	18 0.6×	11 0.4×	13 0.8×	20	152
Bruno Saleme Canada	8	180 1.9×	90 1.0×	28 0.9×	16 0.6×	39 2.3×	12	270
Joke Van Elsen Belgium	3	98 1.0×	96 1.1×	24 0.8×	25 1.0×	7 0.4×	3	146
Hui Gong China	7	213 2.2×	188 2.2×	28 0.9×	38 1.5×	15 0.9×	15	307
Yoshitsugu Oikawa Japan	5	88 0.9×	48 0.6×	21 0.7×	10 0.4×	9 0.5×	9	177
Mélanie Rouleau Canada	11	206 2.1×	104 1.2×	62 2.0×	21 0.8×	8 0.5×	21	368

Countries citing papers authored by Amanda Benjamin

Since Specialization

Citations

This map shows the geographic impact of Amanda Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Benjamin more than expected).

Fields of papers citing papers by Amanda Benjamin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Benjamin. The network helps show where Amanda Benjamin may publish in the future.

Co-authorship network of co-authors of Amanda Benjamin

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Benjamin. A scholar is included among the top collaborators of Amanda Benjamin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Benjamin. Amanda Benjamin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Benjamin, Amanda, et al.. (2017). Use of a collaborative tool to simplify the outsourcing of preclinical safety studies: an insight into the AstraZeneca–Charles River Laboratories strategic relationship. Drug Discovery Today. 22(12). 1754–1759. 1 indexed citations

2.

Curtis, Nicola J., Lorraine Mooney, Filippos Michopoulos, et al.. (2017). Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity. Oncotarget. 8(41). 69219–69236. 121 indexed citations

3.

Gardiner, Philip, et al.. (2016). Neutrophil maturation rate determines the effects of dipeptidyl peptidase 1 inhibition on neutrophil serine protease activity. British Journal of Pharmacology. 173(15). 2390–2401. 19 indexed citations

4.

Benjamin, Amanda, David J. Gallacher, Andrea Greiter‐Wilke, et al.. (2015). Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies. Journal of Pharmacological and Toxicological Methods. 75. 101–110. 4 indexed citations

5.

Benjamin, Amanda, et al.. (2015). Renal Safety Pharmacology in Drug Discovery and Development. Handbook of experimental pharmacology. 229. 323–352. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact